Tregitope applications may include any of the autoimmune diseases that are currently treated almost exclusively with intravenous immunoglobulin G (IVIG), such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN), as well as gene therapy and allergy where Tregitopes may provide a means of inducing antigen-specific tolerance.
Link to the journal: http://www.hindawi.com/journals/jir/2013/493138/
Download pdf: http://downloads.hindawi.com/journals/cdi/2013/493138.pdf